Bioavailability of Technosphere® Insulin Versus Subcutaneous Regular Human Insulin in Type 2 Diabetes
Status:
Completed
Trial end date:
2005-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the kinetics and biodynamics of inhaled Technosphere
Insulin with those of subcutaneous (SC) regular human insulin.